These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9476990

  • 1. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S, Fiorella D, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb; 59(2):419-25. PubMed ID: 9476990
    [Abstract] [Full Text] [Related]

  • 2. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [Abstract] [Full Text] [Related]

  • 3. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.
    Fiorella D, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Oct; 121(3):347-56. PubMed ID: 8584617
    [Abstract] [Full Text] [Related]

  • 4. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA, Winter JC.
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [Abstract] [Full Text] [Related]

  • 5. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
    Fiorella D, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
    [Abstract] [Full Text] [Related]

  • 6. The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus.
    Helsley S, Rabin RA, Winter JC.
    Life Sci; 1997 Oct; 60(9):PL147-53. PubMed ID: 9048970
    [Abstract] [Full Text] [Related]

  • 7. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [Abstract] [Full Text] [Related]

  • 8. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E.
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [Abstract] [Full Text] [Related]

  • 9. Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.
    Helsley S, Rabin RA, Winter JC.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb; 23(2):317-26. PubMed ID: 10368872
    [Abstract] [Full Text] [Related]

  • 10. Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.
    Jones HE, Li H, Balster RL.
    Pharmacol Biochem Behav; 1998 Feb; 59(2):413-8. PubMed ID: 9476989
    [Abstract] [Full Text] [Related]

  • 11. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC, Kieres AK, Zimmerman MD, Reissig CJ, Eckler JR, Ullrich T, Rice KC, Rabin RA, Richards JB.
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [Abstract] [Full Text] [Related]

  • 12. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM, Hard R, Winter JC, Rabin RA.
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [Abstract] [Full Text] [Related]

  • 13. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D, Palumbo PA, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [Abstract] [Full Text] [Related]

  • 14. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC, Helsley S, Fiorella D, Rabin RA.
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB, Rutledge MA, Carbonaro T, Forster MJ.
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [Abstract] [Full Text] [Related]

  • 17. Interactions of clozapine with the stimulus effects of DOM and LSD.
    Palumbo PA, Winter JC.
    Pharmacol Biochem Behav; 1994 Sep; 49(1):115-20. PubMed ID: 7816860
    [Abstract] [Full Text] [Related]

  • 18. Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.
    Eckler JR, Chang-Fong J, Rabin RA, Smith C, Teitler M, Glennon RA, Winter JC.
    Pharmacol Biochem Behav; 2003 Jul; 75(4):845-52. PubMed ID: 12957227
    [Abstract] [Full Text] [Related]

  • 19. Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.
    Zubaran C, Shoaib M, Stolerman IP, Pablo J, Mash DC.
    Neuropsychopharmacology; 1999 Jul; 21(1):119-26. PubMed ID: 10379526
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA, Dave KD, Smolock EM, Aloyo VJ, Harvey JA.
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.